Reuters
"Fonterra, however, told Reuters that it had not yet received any such notice from the FDA itself.
An FDA spokesperson told Reuters in an email response that the FDA had sent letters to some firms, not all, deferring further reviews of applications due to a list of issues.
"For firms that received letters, they do not mean that the infant formulas are unsafe; rather, they indicate that we have found issues that would unlikely be resolved quickly," the spokesperson said.
- Forums
- ASX - By Stock
- A2M
- Deferral is not rejection! This looks like a pause whilst they clean house
Deferral is not rejection! This looks like a pause whilst they clean house, page-25
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.16 |
Change
0.020(0.28%) |
Mkt cap ! $5.176B |
Open | High | Low | Value | Volume |
$7.16 | $7.23 | $7.07 | $18.04M | 2.526M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4213 | $7.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.16 | 17242 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4213 | 7.120 |
2 | 16106 | 7.110 |
2 | 10250 | 7.100 |
6 | 16629 | 7.090 |
3 | 7459 | 7.080 |
Price($) | Vol. | No. |
---|---|---|
7.160 | 17242 | 2 |
7.170 | 3000 | 1 |
7.180 | 20374 | 4 |
7.200 | 3208 | 2 |
7.210 | 7202 | 1 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online